uPA/uPAR and plasmin have previously been recognized as promising therapeutic targets for combating aneurysm progression [67], and we now present a novel chromatin-based mechanism by which the activity of these proteins can be regulated during embryonic vascular development. This evidence concerns the gene PLAU and aneurysm.